A significant data breach has led to a class action lawsuit against pharmaceutical giant Cencora Inc., alleging failure to secure sensitive personal and health information adequately. Filed by Lisa Bledsoe on July 18, 2024, in Pennsylvania's Eastern District Court, the suit seeks damages and improved security measures from Cencora and its subsidiary The Lash Group LLC.
The following cases categorized as "civil" were on the docket in the U.S. District Court for the Eastern District of Pennsylvania on Jan. 26. All case details are allegations only and should not be taken as fact:
Troutman Pepper client Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company, recently announced the initial closing of its Series D financing of up to $37.7 million.
Troutman Pepper Senior Counsel Nina M. Gussack has been recognized among The 2022 Impact 50, a list by City & State Pennsylvania of Pennsylvanians who have dedicated their careers and lives to making the commonwealth a better, safer place to live.
In recognition of her career-long dedication to mentoring and the advancement of women in the legal profession and beyond, the Philadelphia Bar Association will honor Fox Rothschild partner Marilou E. Watson with its prestigious Sandra Day O’Connor Award.
PHILADELPHIA – A federal appellate court has unanimously determined that arbitration proceedings are forthcoming for a class-action lawsuit filed against Merck, which alleged that the pharmaceutical giant discouraged competition for its rotavirus vaccine.
HARRISBURG – Because the terms of a $26 billion national opioid settlement announced last year have not been finalized, the Commonwealth Court of Pennsylvania ruled that litigation brought by the district attorneys of Philadelphia and Allegheny Counties against Pennsylvania Attorney General Josh Shapiro, was premature.
PHILADELPHIA – A federal judge has declared that a lawsuit brought by the City of Philadelphia against several pharmaceutical distributors and retailers for their role in allegedly creating and exacerbating the opioid epidemic in Philadelphia, will be remanded to state court for lack of federal jurisdiction.
